Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Rev-T is an avian retrovirus that specifically transforms early
lymphoid cells in vivo and in vitro. The oncogene of Rev-T is v-
rel; v-rel encodes the transforming protein p59v-rel. v-rel is
derived from a normal cellular gene c-rel, and is highly related to
the Drosophila dorsal gene. We are interested in the mechanism
by which v-rel transforms lymphoid cells, and the reason why it
does not transform fibroblast cells. Using linker insertion and in
vivo mutagenesis we intend to isolate v-rel mutants that are
temperature-sensitive for transformation of lymphoid cells.
These mutants will be used in experiments designed to determine
if p59v-rel is, or is asssociated with, a protein kinase activity
important for its transforming function. If kinase activity does
not seem to be important for the v-rel transforming function we
will attempt to determine a pertinent biochemical function of
p59v-rel using protein purified from bacterial cells expressing the
v-rel protein. We will also determine the sites of phosphorylation
and the identity of a second nuclear directing function in p59v-
rel, and the importance of these sequences for the transforming
function using site-directed mutagenesis. The avian protein p59v-
rel is toxic in murine fibroblasts. We will determine the v-rel
sequences responsible for this toxicity, and whether a non-toxic
avian rel protein can transform murine lymphoid cells. If not, we
will attempt to isolate a murine c-rel cDNA clone, and by in vitro
mutagenesis we will attempt to create a dominant murine rel
transforming gene. Using DNA transfer techniques, we will
attempt to isolate genes from lymphoid cells that will allow
transformation of fibroblast cells. Finally, by making rel-dorsal
hybrid genes in retroviral vectors we will determine whether the
sequence homology between these two genes also reflects a
functional homology between the two proteins. The proposed
studies are intended to further our understanding of retroviral
transforming processes, and may have relevance to lymphoid
tumor development and other normal developmental processes in
general.
No Sub Projects information available for 5R29CA047763-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29CA047763-02
Patents
No Patents information available for 5R29CA047763-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29CA047763-02
Clinical Studies
No Clinical Studies information available for 5R29CA047763-02
News and More
Related News Releases
No news release information available for 5R29CA047763-02
History
No Historical information available for 5R29CA047763-02
Similar Projects
No Similar Projects information available for 5R29CA047763-02